Bruce Kamich is TheStreet's in-house technical analyst with a 43 year career with a number of bulge bracket firms like Morgan Stanley, Smith Barney Harris Upham, and Merrill Lynch. Along the way he accumulated knowledge about the fundamentals of the commodity markets, interest rates, equities and ETFs.
In addition to writing for theStreet.com Kamich has been teaching technical analysis at Baruch College for the past twenty years.
Kamich was one of the earliest Chartered Market Technicians or CMTs, a professional designation similar to the CFA title. He has authored two books on charting and technical analysis - "How Technical Analysis Works" and "Chart Patterns." He is a two-time past president of the Market Technicians Association (now called the CMTA), the professional organization for chartists worldwide. He was also the president of the Market Technicians Association Educational Foundation (MTAEF.org).
MU has endured a lengthy decline and is down to an area that may act as support.
Volume has been heavier in November and December and it looks like longs are bailing out of positions.
Avoid the long side of Biogen as the October low is likely to be tested or broken in the days ahead.
Let's see if a strengthening phase is coming.
Broader market action may be just enough to get FIVE to rally.
We'll be watching to see whether a second-quarter earnings beat and solid guidance trigger more positive signals in the cloud giant's charts.
Shares of the oil giant are still pointed down but the pace of the decline has slowed, so any improvement in oil prices could spark a reversal.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.